Karl Xinqing Chai

Dr. Karl Xinqing Chai


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2003 in The Prostate
Verified
Journal Article
Closed access
PDF file
LCLi‐Mei Chen
Li‐Mei Chen
XZXiaochun Zhang
Xiaochun Zhang
KCKarl Xinqing Chai
Karl Xinqing Chai

26 June 2001 in The Prostate
Verified
Journal Article
Closed access
PDF file
LCLi‐Mei Chen
Li‐Mei Chen
GHG. Byron Hodge
G. Byron Hodge
LGLuis A. Guarda
Luis A. Guarda
JWJames L. Welch
James L. Welch
NGNorman M. Greenberg
Norman M. Greenberg
KCKarl Xinqing Chai
Karl Xinqing Chai

31 May 2008 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
MCMengqian Chen
Mengqian Chen
LCLi-Mei Chen
Li-Mei Chen
CLChen-Yong Lin
Chen-Yong Lin
KCKarl Xinqing Chai
Karl Xinqing Chai

9 October 2001 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
LCLi‐Mei Chen
Li‐Mei Chen
KCKarl Xinqing Chai
Karl Xinqing Chai

22 October 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
LCLi-Mei Chen
Li-Mei Chen
NVNicole J Verity
Nicole J Verity
KCKarl Xinqing Chai
Karl Xinqing Chai
Background: The glycosylphosphatidylinositol (GPI)-anchored epithelial extracellular membrane serine protease prostasin (PRSS8) is expressed abundantly in normal epithelia and essential for terminal epithelial differentiation, but down-regulated in human prostate, breast, and gastric cancers and invasive cancer cell lines. Prostasin is involved in the extracellular proteolytic modulation of the epidermal growth factor receptor (EGFR) and is an invasion suppressor. The aim of this study was to evaluate prostasin expression states in the transitional cell carcinomas (TCC) of the human bladder and in human TCC cell lines. Methods: Normal human bladder tissues and TCC on a bladder cancer tissue microarray (TMA) were evaluated for prostasin expression by means of immunohistochemistry. A panel of 16 urothelial and TCC cell lines were evaluated for prostasin and E-cadherin expression by western blot and quantitative PCR, and for prostasin gene promoter region CpG methylation by methylation-specific PCR (MSP). Results: Prostasin is expressed in the normal human urothelium and in a normal human urothelial cell line, but is significantly down-regulated in high-grade TCC and lost in 9 (of 15) TCC cell lines. Loss of prostasin expression in the TCC cell lines correlated with loss of or reduced E-cadherin expression, loss of epithelial morphology, and promoter DNA hypermethylation. Prostasin expression could be reactivated by demethylation or inhibition of histone deacetylase. Re-expression of prostasin or a serine protease-inactive variant resulted in transcriptional up-regulation of E-cadherin. Conclusion: Loss of prostasin expression in bladder transitional cell carcinomas is associated with epithelial-mesenchymal transition (EMT), and may have functional implications in tumor invasion and resistance to chemotherapy.

13 November 2009 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MCMengqian Chen
Mengqian Chen
LCLi-Mei Chen
Li-Mei Chen
CLChen-Yong Lin
Chen-Yong Lin
KCKarl Xinqing Chai
Karl Xinqing Chai